| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 195.02B | 211.53B | 182.84B | 166.62B | 137.40B | 104.69B |
| Gross Profit | 19.08B | 19.26B | 18.70B | 12.68B | 10.10B | 5.78B |
| EBITDA | 10.80B | 17.73B | 11.07B | 14.97B | 10.08B | -7.12B |
| Net Income | 6.51B | 6.47B | 6.20B | 616.19M | -1.40B | -15.84B |
Balance Sheet | ||||||
| Total Assets | 118.91B | 124.65B | 117.87B | 112.90B | 106.70B | 76.80B |
| Cash, Cash Equivalents and Short-Term Investments | 31.17B | 28.32B | 43.14B | 33.07B | 35.43B | 28.91B |
| Total Debt | 23.68B | 22.46B | 23.17B | 27.25B | 23.88B | 15.28B |
| Total Liabilities | 59.82B | 64.84B | 54.90B | 57.53B | 53.49B | 36.41B |
| Stockholders Equity | 53.83B | 54.70B | 55.32B | 48.16B | 46.58B | 37.94B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 11.12B | 15.17B | 10.87B | 8.31B | 1.97B |
| Operating Cash Flow | 0.00 | 18.77B | 20.79B | 16.35B | 13.31B | 6.21B |
| Investing Cash Flow | 0.00 | -11.49B | -840.45M | -15.10B | -13.11B | -11.12B |
| Financing Cash Flow | 0.00 | -14.77B | -11.49B | -5.55B | 1.48B | 16.60B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$100.69B | 9.94 | 7.51% | ― | 18.89% | 6.97% | |
74 Outperform | HK$153.10B | 11.17 | 14.02% | 3.05% | 11.02% | 4.17% | |
65 Neutral | HK$45.83B | 5.91 | 9.97% | 6.39% | -8.36% | 3.10% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | HK$12.18B | 4.20 | 8.00% | 3.55% | -3.33% | -8.42% | |
62 Neutral | HK$2.71B | 17.02 | 9.22% | 8.25% | -3.77% | -65.34% | |
61 Neutral | HK$90.85B | 25.39 | 5.53% | ― | 18.42% | 97.52% |